PHARMACYTE BIOTECH, INC. Derivative Liability
PHARMACYTE BIOTECH, INC. (PMCB) had Derivative Liability of $29.75 thousand as of 2015-10-31, per its 10-Q filed 2015-12-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2015-12-10
- 2015-10-31: Derivative Liability $29.75K.
- 2015-04-30: Derivative Liability $492.05K.
| Period end | Derivative Liability |
|---|---|
| 2015-10-31 | $29.75K 10-Q · filed 2015-12-10 |
| 2015-04-30 | $492.05K 10-Q · filed 2015-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |